John M Burke

17PUBLICATIONS
77CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursRadiation therapyGene mappingApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Jun 02, 2026
Consolidation of Oncology Practices.

|Dec 29, 2025
Brentuximab vedotin and nivolumab in combination with chemotherapy for nonbulky, early-stage classical Hodgkin lymphoma.

Jeremy S Abramson, David J Straus, Nancy L Bartlett

|Jun 06, 2025
Phase III Trial of Pirtobrutinib Versus Idelalisib/Rituximab or Bendamustine/Rituximab in Covalent Bruton Tyrosine Kinase Inhibitor-Pretreated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (BRUIN CLL-321).

Jeff P Sharman, Talha Munir, Sebastian Grosicki

|May 07, 2025
Zanubrutinib is well tolerated and effective in patients with CLL/SLL intolerant of ibrutinib/acalabrutinib: updated results.

Mazyar Shadman, John M Burke, Jennifer Cultrera

|Mar 13, 2025
Real-World Effectiveness of Frontline Treatments Among Patients with Chronic Lymphocytic Leukemia: Results from ConcertAI.

Lindsey E Roeker, John M Burke, Joanna M Rhodes

|Feb 05, 2025
State of Professional Well-Being, Satisfaction, and Career Plans Among US Oncologists in 2023.

Caroline Schenkel, Laura A Levit, Kelsey Kirkwood

Pageof 3

Frequent Collaborators

2 joint publications

Manish R Patel

2 joint publications

Ray D Page

2 joint publications

Chan Y Cheah

2 joint publications

Tycel Phillips